Charles River Laboratories International (CRL) Gross Margin (2009 - 2025)
Charles River Laboratories International (CRL) posted quarterly Gross Margin of 182.51% for Q4 2025, up 8658.0% year-over-year from 2.08% in Q4 2024, and up 104.93% quarter-over-quarter from 89.06% in Q3 2025.
Charles River Laboratories International (CRL) Gross Margin (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Gross Margin history runs 17 years deep, the most recent figure standing at 182.51% for Q4 2025.
- In Q4 2025, Gross Margin rose 8658.0% year-over-year to 182.51%; the TTM figure through Dec 2025 stood at 110.66% (up 3168.0% YoY), while the FY2025 annual figure was 89.3%, down 151.0% from the prior year.
- Gross Margin for Q4 2025 stood at 182.51%, up from 89.06% in the prior quarter.
- The five-year high for Gross Margin was 262.47% in Q4 2023, with the low at 35.25% in Q3 2023.
- The 5-year median for Gross Margin is 89.74% (2021), against an average of 104.06%.
- The sharpest annual moves came in 2021 and 2024: Gross Margin surged 12111 bps in 2021, then plunged 16655 bps in 2024.
- Charles River Laboratories International's Gross Margin stood at 210.64% in 2021, then declined by 6 bps to 198.61% in 2022, then soared by 32 bps to 262.47% in 2023, then tumbled by 63 bps to 95.92% in 2024, then jumped by 90 bps to 182.51% in 2025.
- Business Quant data shows CRL's Gross Margin at 182.51% in Q4 2025, 89.06% in Q3 2025, and 86.13% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 69.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 57.64% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 64.04% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 53.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 32.85% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 99.91% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 66.44% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 63.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 33.75% |
| 10 | Charles River Laboratories International | 12.89 Bn | 12.68 Bn | 1.81 Bn | 182.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 182.51% |
| Sep 27, 2025 | 89.06% |
| Jun 28, 2025 | 86.13% |
| Mar 29, 2025 | 85.85% |
| Dec 28, 2024 | 95.92% |
| Sep 28, 2024 | 90.88% |
| Jun 29, 2024 | 43.73% |
| Mar 30, 2024 | 86.07% |
| Dec 30, 2023 | 262.47% |
| Sep 30, 2023 | 35.25% |
| Jul 1, 2023 | 37.64% |
| Apr 1, 2023 | 36.69% |
| Dec 31, 2022 | 198.61% |
| Sep 24, 2022 | 91.08% |
| Jun 25, 2022 | 90.36% |
| Mar 26, 2022 | 90.13% |
| Dec 25, 2021 | 210.64% |
| Sep 25, 2021 | 89.95% |
| Jun 26, 2021 | 89.52% |
| Mar 27, 2021 | 88.80% |